Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The National HealthCare Corporation (NHC) SEC filings page provides access to the company’s regulatory disclosures as a NYSE American issuer. NHC’s common stock, with a par value of $0.01 per share, is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades under the symbol NHC. Through its affiliates, the company operates skilled nursing facilities, assisted living and independent living communities, behavioral health hospitals, homecare agencies, and hospice agencies, along with Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and management and accounting services to third party post-acute operators.
In its Form 8-K current reports, NHC discloses material events such as quarterly and annual earnings releases, dividend declarations, and significant lease and governance matters. For example, the company files 8-Ks to furnish earnings press releases for periods ended March 31, June 30, September 30, and December 31, and to announce quarterly common dividends. These filings often reference non-GAAP financial measures and include or incorporate reconciliations to GAAP results.
NHC’s 8-K filings also describe corporate governance and executive changes, including the appointment of new directors, committee assignments, and planned retirements of senior officers, as well as role changes for executives. Additional 8-Ks address lease arrangements, such as disclosures about a master lease with National Health Investors, Inc., letters alleging non-monetary non-compliance, cure periods, renewal options, and the potential for a material adverse impact on NHC’s financial position and results of operations if certain lease rights were lost.
On this page, users can review NHC’s SEC reports as they are made available through EDGAR and use AI-powered summaries to understand the key points in lengthy filings. These tools can help clarify topics such as segment reporting for inpatient services and home care hospice services, dividend practices, lease terms and disputes, and board and executive leadership changes, without replacing the full text of the official documents.
National Healthcare Corp CEO and director Stephen Fowler Flatt received a grant of 20,000 options to purchase common stock on February 23, 2026 under the 2020 Omnibus Equity Incentive Plan. The options have a stated exercise price of $0.00 per share in the filing.
These stock options vest and become exercisable in three equal installments: one-third on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. After this grant, Flatt directly holds 20,000 of these options, alongside separately reported existing option and common stock holdings.
National Healthcare Corp SVP and CFO Brian F. Kidd received a grant of 14,000 options to purchase common stock on February 23, 2026. The options were granted at an exercise price of $0.00 under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
The options vest ratably over three years, with one-third vesting on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. As of this grant, Kidd also directly held other option positions and 23,717 shares of common stock.
FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president and CIO Ben Anderson Flatt Sr reported an equity award of stock options. On February 23, 2026, he received options to purchase 14,000 shares of common stock under the 2020 Omnibus Equity Incentive Plan.
These options vest in three equal installments: one‑third on February 23, 2027, one‑third on February 23, 2028, and the final one‑third on February 23, 2029. The award is structured as long‑term incentive compensation rather than an open‑market share purchase.
NATIONAL HEALTHCARE CORP reported that Sr. VP of Operations Timothy J. Shelly received a grant of stock options to purchase 14,000 shares of common stock on February 23, 2026. The options were granted at an exercise price reported as
The options were issued under the company’s 2020 Omnibus Equity Incentive Plan and will vest ratably over three years. One-third will vest on February 23, 2027, another one-third on February 23, 2028, and the final one-third on February 23, 2029, after which they become exercisable.
National HealthCare Corporation expanded its Board of Directors from seven to nine members effective February 12, 2026, appointing Dr. David Gifford and Andrew Adams as independent directors. Gifford joins as a Class 2 Director, expected to stand for a three‑year term at the 2027 annual meeting. Adams joins as a Class 1 Director and will be nominated for a three‑year term at the 2026 annual meeting.
Dr. Gifford brings long experience in geriatrics, public health leadership and long‑term care policy, while Adams contributes prior NHC facility administration experience and current leadership of a multilocation financial services business. Gifford will serve on the Nominating and Corporate Governance Committee and Adams on the Compensation Committee, and both will receive NHC’s standard non‑employee director compensation and indemnification.
National HealthCare Corporation announced a regular quarterly cash dividend of $0.64 per common share. The dividend will be paid to shareholders of record on March 31, 2026, with payment scheduled for April 30, 2026, reinforcing its ongoing cash return to shareholders.
As of February 1, 2026, NHC affiliates operate 80 skilled nursing facilities with 10,329 beds, 26 assisted living communities with 1,413 units, and nine independent living communities with 777 units, along with behavioral health hospitals, homecare, hospice, pharmacy, and rehabilitation services.
National Healthcare Corp (NHC) director James Paul Abernathy reported an option exercise and related share withholding. On January 15, 2026, he exercised an option granted in 2022 for 7,500 shares of common stock at a price of $69.82 per share. The company withheld 3,732 shares at $139.01 per share to pay the exercise price, resulting in net additional shares held.
Following these transactions, Abernathy beneficially owns 40,162 shares of NHC common stock, held directly. The exercised options were granted under the company’s 2020 Omnibus Equity Incentive Plan and are noted as exempt from certain short-swing profit rules. He also continues to hold option grants from 2023, 2024 and 2025, each covering 7,500 shares of common stock.
National Healthcare Corp Senior VP & General Counsel reported an equity transaction involving company stock. On 1/1/2026, a total of 1,162 shares of restricted stock that were originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. To cover tax obligations from this vesting, the company withheld 496 shares, recorded as a disposition at a price of
After this tax withholding, the insider directly beneficially owns 9,942 shares of National Healthcare Corp common stock. The filing also lists outstanding stock options giving rights to purchase additional shares in the future, all held directly by the reporting person.
National Healthcare Corp (NHC) insider equity update: A Form 4 reports that President & COO Michael Ussery had 2,063 shares of common stock withheld on 12/31/2025, coded as an "F" transaction. This reflects shares surrendered to cover tax obligations related to vesting equity awards, rather than an open-market sale. The shares were valued at $137.09 each for this tax withholding transaction, and following it, Ussery beneficially owned 158,460 shares of NHC common stock. An accompanying note explains that on 1/1/2026, a total of 4,835 restricted shares granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested, with the 2,063 shares withheld by the company to satisfy tax requirements.
National Healthcare Corp executive reports share withholding for taxes and updates equity awards. A Senior VP & CIO of NATIONAL HEALTHCARE CORP (NHC) reported a Form 4 transaction dated 01/01/2026. On that date, 33 1/3% (1,070 shares) of previously granted restricted stock vested from awards originally granted on 3/8/2023, 3/5/2024, and 3/5/2025. The company withheld 403 shares, coded as an "F" transaction, at a price of $137.09 per share to cover tax obligations. Following this transaction, the officer beneficially owned 14,117.0547 shares of common stock held directly.
The filing also lists outstanding stock options held directly by the officer. These include an option to purchase 7,467 shares of common stock at $53.94 per share expiring 03/08/2028, an option to purchase 12,000 shares at $94.10 per share expiring 03/05/2029, and an option to purchase 13,500 shares at $90.62 per share expiring 02/24/2030.